US halts AstraZeneca’s Covid-19 vaccine production at Baltimore plant: report

The move came, days after the facility ruined 15 million doses of J&J shots, after the Maryland-based biotech firm, Emergent BioSolutions, accidentally mixed up the ingredients from the two vaccines, which forced regulators to delay approval of the plant’s output, the NYT report said